Clinical Trials Directory

Trials / Unknown

UnknownNCT02477176

Lumbar Discectomy Control Study, Risk Factors for Reherniation

A Prospective, Multicenter Study Investigating Reherniation Risk Factors and Associated Costs in Primary Lumbar Disc Herniation Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Intrinsic Therapeutics · Industry
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this 12-month, prospective, multicenter study is to investigate the effect of annular defect size and other risk factors on reherniation and associated costs in primary lumbar discectomy patients.

Detailed description

This study will enroll up to 100 patients at select US (approximately 4-7) sites. Patients that are scheduled for an L1-S1 discectomy and who meet the pre-operative eligibility criteria will be considered for study participation. Patients will be divided into two arms (small- and large-defect) based on the size of their annular defect as measured intra-operatively; each arm will be capped at 50 patients. All patients included in the trial will be followed for at least 12 months.

Conditions

Interventions

TypeNameDescription
OTHERDiscectomyLumbar discectomy

Timeline

Start date
2016-02-17
Primary completion
2024-03-01
Completion
2025-03-01
First posted
2015-06-22
Last updated
2023-09-28

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02477176. Inclusion in this directory is not an endorsement.